dc.contributor.author | Henshall, Catherine | |
dc.date.accessioned | 2019-07-23T10:08:38Z | |
dc.date.available | 2019-07-23T10:08:38Z | |
dc.date.issued | 2018-07 | |
dc.identifier.citation | Catherine Henshall, Parth Narendran, Robert C Andrews,Amanda Daley, Keith A Stokes,Amy Kennedy, Sheila Greenfield.Qualitative study of barriers to clinical trial retention in adults with recently diagnosed type 1 diabetes.BMJ Open 2018;8:e022353. | en |
dc.identifier.issn | 2044-6055 | |
dc.identifier.uri | https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/295 | |
dc.description | This is an open access article distributed in accordance with the
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which
permits others to distribute, remix, adapt, build upon this work non-commercially,and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use
is non-commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/. | en |
dc.description.abstract | Objectives: Regular physical exercise may preserve β cell
function in newly diagnosed adults with type 1 diabetes
(T1D). However, clinical trials to test this theory require the
recruitment and retention of adults with new-onset T1D,
which can be challenging. We sought to determine the
overall experiences of newly diagnosed adults with T1D in
an exercise study, to understand issues that influence the
retention of trial participants in such studies.
Design: Qualitative methodology using individual faceto-
face (n=6) and telephone interviews (n=14). Interview
transcripts were thematically analysed using the
framework method.
Setting: The study took place at five participating UK
hospitals.
Participants: Twenty participants, aged 19–55 years, in
the Exercise for Type 1 Diabetes study were interviewed to
explore their study experiences and identify motivators and
deterrents towards the study. Participants in control and
intervention arms were interviewed, as were people with
T1D who had completed (n=16) and withdrawn (n=4).
Results Participants revealed barriers and facilitators to
retention; the majority were generalisable to clinical trials
of people with newly diagnosed T1D. Coming to terms
with a diagnosis of T1D, lack of time, work pressures,
level of health professional support, volume, clarity and
consistency of information and feedback and a desire
for knowledge about their condition were all cited as
influencing factors to trial retention.
Conclusions: To our knowledge, this is the first qualitative
study to examine the experience of being involved in
an exercise trial by people with T1D. Findings suggest
appointments could be shorter, available outside of
working hours and planned longer in advance; study
information should be clear, consistent and in electronic
and paper formats; questionnaires need minimising;
healthcare support and feedback needs providing
regularly; thought is required around how to support
non-exercising arm participants. These considerations
may improve participant retention rates in new-onset T1D
studies | en |
dc.description.sponsorship | Supported by the NIHR | en |
dc.description.uri | http:// dx. doi.org/ 10. 1136/ bmjopen- 2018-022353 | |
dc.language.iso | en | en |
dc.subject | Diabetes | en |
dc.subject | Exercise | en |
dc.subject | Recruitment (Trials) | en |
dc.subject | Retention (Trials) | en |
dc.title | Qualitative study of barriers to clinical trial retention in adults with recently diagnosed type 1 diabetes | en |
dc.type | Article | en |